Annual report [Section 13 and 15(d), not S-K Item 405]

SCHEDULE OF SEGMENT INFORMATION (Details)

v3.25.4
SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Product Information [Line Items]    
Net Revenue $ 6,161,959 $ 9,362,022
Total operating loss (10,572,508) (8,953,445)
Non-operating expense, net (4,293,204) (74,736)
Net loss before income taxes (14,865,712) (9,028,181)
Income tax expense (44,042) (11,650)
Net loss (14,909,754) (9,039,831)
Diagnostic Research And Development [Member]    
Product Information [Line Items]    
Net Revenue 577 8,654
Total operating loss (2,089,103) (1,782,882)
Laboratory Services [Member]    
Product Information [Line Items]    
Net Revenue 6,161,382 9,353,368
Total operating loss (6,952,050) (9,946,452)
General Corporate Activities [Member]    
Product Information [Line Items]    
Total operating loss $ (7,693,314) $ (6,586,133)